MIRA
Mira Pharmaceuticals, Inc.Company with tickers: MIRA
CIK
1904286
CUSIP
60458C104
Shares Outstanding
42,022,087
Website
https://www.facebook.com
Investor Relations
https://www.facebook.com/investor
13F Activity (30d)
10 filings
10 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $1,103,479 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $524,781 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | — | ||||
| Net Income | $-1,150,152 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.03 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.03 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |